A new type of cell-based immunotherapy shows promise for B-cell lymphomas and - due to innovations in manufacturing - could make future cellular immunotherapies less expensive and more accessible to ...

These tiny terminators, called natural killer (NK) cells, are one of the body’s strongest defences against illness and disease — and yet the hundreds of billions of NK cells in our own bodies ...